Sana Biotechnology Inc vs Vertiv Holdings Co — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Vertiv Holdings Co trades at $305.72 (market cap $112.03B). The key difference: Vertiv Holdings Co is far larger — about 128.2× Sana Biotechnology Inc's market cap, and Vertiv Holdings Co pays a 0.09% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | VRT | |
|---|---|---|
Market Cap | $873.84M | $112.03B |
Sector | Health | Technology |
52-Week High | $5.92 | $376.23 |
52-Week Low | $2.68 | $121.82 |
Enterprise Value | $848.03M | $112.80B |
Dividend Yield | — | 0.09% |
Trailing returns across standard periods
Latest headlines on both assets
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →